Showing results (11-20 of 352) with videos related to
Sort By:
Pageof 36
Kidney International|February 21, 2019
The elusive podocyte crossmatch for recurrent focal segmental glomerulosclerosisGeorge W Burke, Alessia FornoniThe Journal of Pathology|October 3, 2020
Bedside to bench Alport syndrome research: are human urine-derived podocytes the answer?†Jin-Ju Kim, Alessia FornoniKidney Research and Clinical Practice|October 21, 2015
Nonimmunologic targets of immunosuppressive agents in podocytesTae-Hyun Yoo, Alessia FornoniTransactions of the American Clinical and Climatological Association|July 23, 2013
Circulating permeability factor suPAR: from concept to discovery to clinicJochen ReiserCells|June 19, 2024
Normal and Dysregulated Sphingolipid Metabolism: Contributions to Podocyte Injury and BeyondMatthew Tolerico, Sandra Merscher, Alessia FornoniTransplantation|July 12, 2013
Podocyte effacement closely links to suPAR levels at time of posttransplantation focal segmental glomerulosclerosis occurrence and improves with therapyNada Alachkar, Changli Wei, Lois J Arend, et al.Glomerular Diseases|February 8, 2023
Lupus Membranous NephropathyClaudio Ponticelli, Gabriella Moroni, Alessia FornoniPharmaceutics|May 27, 2023
Unraveling the Crosstalk between Lipids and NADPH Oxidases in Diabetic Kidney DiseaseRachel Njeim, Sahar Alkhansa, Alessia FornoniJournal of Personalized Medicine|August 27, 2021
Use of Lipid-Modifying Agents for the Treatment of Glomerular DiseasesMengyuan Ge, Sandra Merscher, Alessia FornoniPageof 36